MyFinsight
Home
About
Contact
Back
Income Statement
NewAmsterdam Pharma Co N.V. (NAMS)
source: myfinsight.com
Download
Download image
Total comprehensive
loss for the period,...
-$17,471K
Loss for the period
-$17,364K
Unrealized gain/(loss) on
available-for-sale securities, net...
-$107K
Loss before tax
-$17,364K
Fair value change -
warrants
-$2,590K
Foreign exchange
gains/(losses)
$8,626K
Interest income
$7,055K
Operating loss
-$35,635K
Revenue
$19,145K
Total operating
expenses
$54,780K
Research and development
expenses
$27,516K
Selling, general and
administrative expenses
$27,264K
Back